A NOVEL COMPOUND FOR THE TREATMENT OF EWING SARCOMA AND HIGH-THROUGHPUT ASSAYS FOR IDENTIFYING SMALL MOLECULES THAT MODULATE ABERRANT CHROMATIN ACCESSIBILITY
DAVIS, Ian,JIN, Jian,JANZEN, William P.,PATTENDEN, Samantha,JAYAKODY, Chatura
申请号:
USUS2016/028627
公开号:
WO2016/172332A1
申请日:
2016.04.21
申请国别(地区):
WO
年份:
2016
代理人:
摘要:
The present invention provides a compound useful for the treatment of cancer, and in particular, treatment of Ewing sarcoma. The present invention further provides an assay for identifying a compound that modulates chromatin activity of EWS-FLI1.La présente invention concerne un composé utile pour le traitement du cancer, et en particulier, le traitement du sarcome dEwing. La présente invention concerne, en outre, un dosage permettant didentifier un composé qui module lactivité de la chromatine dEWS-FLI1.